167 related articles for article (PubMed ID: 33948723)
1. Recurrent Wnt medulloblastoma treated with marrow-ablative chemotherapy and autologous hematopoietic progenitor cell rescue: a dual case report and review of the literature.
Harris MK; Shatara M; Funk Z; Stanek J; Boué DR; Jones J; Finlay JL; Abdelbaki MS
Childs Nerv Syst; 2022 Feb; 38(2):465-472. PubMed ID: 33948723
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
3. Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.
Shatara M; Blue M; Stanek J; Liu YA; Prevedello DM; Giglio P; Puduvalli VK; Gardner SL; Allen JC; Wong KK; Nelson MD; Gilles FH; Adams RH; Pauly J; O'Halloran K; Margol AS; Dhall G; Finlay JL
Neurooncol Pract; 2024 Apr; 11(2):188-198. PubMed ID: 38496907
[TBL] [Abstract][Full Text] [Related]
4. Wnt activation as a therapeutic strategy in medulloblastoma.
Manoranjan B; Venugopal C; Bakhshinyan D; Adile AA; Richards L; Kameda-Smith MM; Whitley O; Dvorkin-Gheva A; Subapanditha M; Savage N; Tatari N; McKenna D; Bassey-Archibong B; Winegarden N; Hallett R; Provias JP; Yarascavitch B; Ajani O; Fleming A; Bader GD; Pugh TJ; Doble BW; Singh SK
Nat Commun; 2020 Aug; 11(1):4323. PubMed ID: 32859895
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases.
Millot F; Delval O; Giraud C; Bataille B; Babin P; Germain T; Sadoun A; Vandermarq P; Guilhot F
Bone Marrow Transplant; 1999 Dec; 24(12):1347-9. PubMed ID: 10627646
[TBL] [Abstract][Full Text] [Related]
7. Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma.
Abdel-Azim H; Kapoor N; Mahadeo KM; Finlay JL
Pediatr Blood Cancer; 2015 Sep; 62(9):1667-9. PubMed ID: 25894457
[TBL] [Abstract][Full Text] [Related]
8. Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
Syst Rev; 2020 Mar; 9(1):47. PubMed ID: 32127049
[TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
10. [High dose ACNU and radiation therapy with autologous bone marrow rescue for a patient with cerebellar medulloblastoma: case report].
Matsumoto M; Yamashita J; Okamoto S; Handa H; Sawada H; Abe M
No Shinkei Geka; 1984 May; 12(6):731-6. PubMed ID: 6379491
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: an Old Diagnosis with New Promises.
Szalontay L; Khakoo Y
Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
[TBL] [Abstract][Full Text] [Related]
12. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
[TBL] [Abstract][Full Text] [Related]
13. WNT-activated medulloblastoma with melanotic and myogenic differentiation: Report of a rare case.
Rajeshwari M; Kakkar A; Nalwa A; Suri V; Sarkar C; Satyarthee GD; Garg A; Sharma MC
Neuropathology; 2016 Aug; 36(4):372-5. PubMed ID: 26869281
[TBL] [Abstract][Full Text] [Related]
14. Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.
Kostaras X; Easaw JC
J Neurooncol; 2013 Oct; 115(1):1-8. PubMed ID: 23877361
[TBL] [Abstract][Full Text] [Related]
15. Desmoplastic nodular medulloblastoma in young children: a management dilemma.
AbdelBaki MS; Boué DR; Finlay JL; Kieran MW
Neuro Oncol; 2018 Jul; 20(8):1026-1033. PubMed ID: 29156007
[TBL] [Abstract][Full Text] [Related]
16. Anomalous vascularization in a Wnt medulloblastoma: a case report.
Di Giannatale A; Carai A; Cacchione A; Marrazzo A; Dell'Anna VA; Colafati GS; Diomedi-Camassei F; Miele E; Po A; Ferretti E; Locatelli F; Mastronuzzi A
BMC Neurol; 2016 Jul; 16():103. PubMed ID: 27416922
[TBL] [Abstract][Full Text] [Related]
17. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
20. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience.
Abdelbaki MS; Abu-Arja MH; Davidson TB; Fangusaro JR; Stanek JR; Dunkel IJ; Dhall G; Gardner SL; Finlay JL
Pediatr Blood Cancer; 2020 Jun; 67(6):e28252. PubMed ID: 32187454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
